The presence of microplastics in human tissues poses health risks

What's this about?

People disagree about whether microplastics (tiny bits of plastic) in our bodies can harm our health.

Scientists have found them in human blood and organs, but they still lack proof that these bits cause illness.

What supporters say

• Human tissues can hold plastic bits that may harm cells, cause swelling, and change how the body works.
• Studies link plastic exposure with weaker sperm and show plastic bits near the place where babies grow.
• One study found plastic bits in artery clumps, and those people later had more heart problems.

What critics say

• Lab tests often use more plastic, or different kinds, than people meet in real life.
• Scientists have not yet shown that plastic bits directly cause human disease, because other causes may explain the results.

How to read this

The number of points on each side does not show who is right; the strength of the proof matters more.

The bottom line

The evidence shows a real reason for concern, but it does not yet prove that microplastics cause disease in people.

The risk may change with the bit’s size, type, dose, and added chemicals, so scientists need more study.

Microplastics have been found in human blood and organs, raising concerns that they may do more than show exposure. The evidence suggests a credible potential health hazard, but it has not yet proved that the particles cause disease in people.

The case for

Researchers have detected microplastics in blood, lungs, placentas and cardiovascular tissue. This indicates that the particles can move beyond the places where they enter the body and remain in human tissues. 1 (see Figure 3) Laboratory studies also report possible effects including inflammation, oxidative stress, immune-system changes, cell damage, disruption of mitochondria and genetic harm. Some studies suggest hormone-related effects as well.

Together, these findings make harm biologically plausible. But they do not show how large the risk is. Results vary depending on the particle’s size, plastic type, surface chemistry, additives and dose.

The strongest human outcome signal so far comes from cardiovascular research. In one prospective study of patients having surgery for blocked neck arteries, researchers found polyethylene and other particles in some artery plaques. Those patients later had more cardiovascular events than patients whose plaques did not contain detected particles. 2 This is a more direct link to human disease than cell experiments provide, although the study was observational. Other factors could explain the difference, and the disease itself might have affected where particles accumulated.

Reproductive research provides another reason for concern. A study across several sites linked mixed microplastic exposure with signs of impaired sperm function. Other research found particles at the placenta, where maternal and fetal tissues meet. 3 Experimental studies offer possible explanations for these findings, but the placental research involved a small sample, and the sperm study depended on uncertain estimates of exposure.

The case against

The central problem is that human disease causation remains unproven. Many studies are small, cross-sectional or based on selected groups. They often measure the presence of particles without tracking validated health outcomes over time. As a result, associations involving cardiovascular disease or sperm function could reflect underlying illness, other exposures or differences between participants rather than an effect caused by particles in tissue. 4

Laboratory and animal findings also may not reflect ordinary human exposure. 5 Many experiments use clean, newly manufactured particles, doses higher than people normally encounter, short exposure periods or plastics unlike the varied mixtures found in the environment. Effects seen under those conditions cannot be directly converted into the level of risk faced by the average person.

Measuring the particles is itself difficult. They are widespread, small and chemically varied, and samples can be contaminated during collection or testing. Researchers also use different methods to identify plastic type, particle size and concentration. These differences make results harder to compare and make estimates of the amount stored in human tissues less certain.

These limitations do not erase repeated evidence that people are exposed and that particles can reach tissues. But they leave major questions unanswered about dose, duration, particle characteristics and individual susceptibility. Reviews and public-health research agendas identify these gaps as priorities. (see Figure 2)

The bottom line

The evidence favours treating microplastics in human tissues as a credible potential health hazard, but only with moderate confidence when the claim is read as saying they cause clinically meaningful disease. Confidence is high that exposure and tissue distribution are real findings. It is much lower that any measured tissue burden causes a specific illness or creates a known level of risk for the average person.

The strongest evidence shows biological activity and some human health associations. The strongest objections are equally important: the studies do not yet establish causation, and experimental conditions may not match real-world exposure. The key missing evidence is robust, long-term human research linking measured tissue burdens to confirmed clinical outcomes.